<body> <div id="shinytab4" class="section level2">&#13;
<h2>Further Information</h2>&#13;
<ul><li>For this app, the underlying script and function running the simulation is called <code>simulate_virus_tx.R</code>. Read the help file for the function to see how you can call it directly.</li>&#13;
<li>For some examples of models that were used to study antivirals in acute infections, specifically influenza, see e.g. <span class="citation">(Handel, Longini, and Antia 2007; Beauchemin et al. 2008; Canini et al. 2014)</span>.</li>&#13;
<li>For some examples of models that were applied to antiviral treatment in chronic infections (HIV, HCV), see e.g. <span class="citation">(Neumann et al. 1998; Dixit et al. 2004)</span>.</li>&#13;
</ul><div id="references" class="section level3 unnumbered">&#13;
<h3>References</h3>&#13;
<div id="refs" class="references">&#13;
<div id="ref-beauchemin08">&#13;
<p>Beauchemin, Catherine A A, James J McSharry, George L Drusano, Jack T Nguyen, Gregory T Went, Ruy M Ribeiro, and Alan S Perelson. 2008. “Modeling Amantadine Treatment of Influenza a Virus in Vitro.” <em>Journal of Theoretical Biology</em> 254 (2): 439–51. doi:<a href="https://doi.org/10.1016/j.jtbi.2008.05.031">10.1016/j.jtbi.2008.05.031</a>.</p>&#13;
</div>&#13;
<div id="ref-canini14a">&#13;
<p>Canini, Laetitia, Jessica M Conway, Alan S Perelson, and Fabrice Carrat. 2014. “Impact of Different Oseltamivir Regimens on Treating Influenza a Virus Infection and Resistance Emergence: Insights from a Modelling Study.” <em>PLoS Computational Biology</em> 10 (4): e1003568. doi:<a href="https://doi.org/10.1371/journal.pcbi.1003568">10.1371/journal.pcbi.1003568</a>.</p>&#13;
</div>&#13;
<div id="ref-dixit04">&#13;
<p>Dixit, Narendra M, Jennifer E Layden-Almer, Thomas J Layden, and Alan S Perelson. 2004. “Modelling How Ribavirin Improves Interferon Response Rates in Hepatitis c Virus Infection.” <em>Nature</em> 432 (7019): 922–24. doi:<a href="https://doi.org/10.1038/nature03153">10.1038/nature03153</a>.</p>&#13;
</div>&#13;
<div id="ref-handel07">&#13;
<p>Handel, Andreas, Ira M Longini Jr, and Rustom Antia. 2007. “Neuraminidase Inhibitor Resistance in Influenza: Assessing the Danger of Its Generation and Spread.” <em>PLoS Comput Biol</em> 3 (12). Department of Biology, Emory University, Atlanta, Georgia, United States of America. ahandel@emory.edu: e240. doi:<a href="https://doi.org/10.1371/journal.pcbi.0030240">10.1371/journal.pcbi.0030240</a>.</p>&#13;
</div>&#13;
<div id="ref-neumann98">&#13;
<p>Neumann, A U, N P Lam, H Dahari, D R Gretch, T E Wiley, T J Layden, and A S Perelson. 1998. “Hepatitis c Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-Alpha Therapy.” <em>Science (New York, N.Y.)</em> 282 (5386): 103–7.</p>&#13;
</div>&#13;
</div>&#13;
</div>&#13;
</div> </body>
